Loading
CC
CONTRAFECT Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Messinger Michael, was filed 16 Dec 2019.
CONTRAFECT Corp: what insiders have been doing
CONTRAFECT Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). CONTRAFECT Corp has had no insider filing for more than a year; the last one goes back to 16 December 2019.
Looking back to 2014, when coverage begins, insiders filed 17 purchases and 7 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
32
Thresholds
n/a
Buy Volume
€375,649
17 ops. · all time
Sell Volume
€1M
7 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
Net income-58.1M
Last declaration on 16 December 2019
Declarations32 total
5,000 shares@ US$0.37100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-19-060539:0
Canonical exit: 12 Mar 2020 (T+90)
300,000 shares@ US$0.43100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-19-060535:0
Canonical exit: 12 Mar 2020 (T+90)
50,000 shares@ US$0.39100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-19-060537:0
Canonical exit: 12 Mar 2020 (T+90)
600,000 shares@ US$2.04100.0% of flowCommon StockSEC:0001144204-18-063392:0
▼
Same trade as the filing by Shanghai Fosun Pharmaceutical (Group) Co., Ltd., counted once
1M USD25SEC
600,000 shares@ US$2.04100.0% of flowCommon StockSEC:0001144204-18-063394:0
16,000 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046446:0
Canonical exit: 23 Oct 2017 (T+90)
8,000 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046328:0
Canonical exit: 23 Oct 2017 (T+90)
9,600 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046321:0
Canonical exit: 23 Oct 2017 (T+90)
8,000 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046317:0
Canonical exit: 23 Oct 2017 (T+90)
800 shares@ US$1.2434.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046330:0
Canonical exit: 23 Oct 2017 (T+90)
800 shares@ US$1.241.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046310:0
Canonical exit: 23 Oct 2017 (T+90)
2,000 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046333:0
Canonical exit: 23 Oct 2017 (T+90)
40,000 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046312:0
Canonical exit: 23 Oct 2017 (T+90)
40,000 shares@ US$1.2427.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046315:0
Canonical exit: 23 Oct 2017 (T+90)
12,000 shares@ US$1.2442.3% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046323:0
Canonical exit: 23 Oct 2017 (T+90)
800 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046325:0
Canonical exit: 23 Oct 2017 (T+90)
800 shares@ US$1.24100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-17-046319:0
Canonical exit: 23 Oct 2017 (T+90)
20,000 shares@ US$2.4898.1% of flowCommon Stock, par value $0.0001 per shareSEC:0001209191-16-134126:0
Canonical exit: 25 Oct 2016 (T+90)
2,872 shares@ US$3.81Common Stock, par value $0.0001 per shareSEC:0001209191-15-081166:0
2,867 shares@ US$4.23Common Stock, par value $0.0001 per shareSEC:0001209191-15-078442:0
2,867 shares@ US$4.48Common Stock, par value $0.0001 per shareSEC:0001209191-15-076487:0
2,867 shares@ US$4.11Common Stock, par value $0.0001 per shareSEC:0001209191-15-074845:0
2,867 shares@ US$4.76Common Stock, par value $0.0001 per shareSEC:0001209191-15-071896:0
2,867 shares@ US$4.90Common Stock, par value $0.0001 per shareSEC:0001209191-15-070132:0
11,778 shares@ US$4.61Common Stock, par value $0.0001 per shareSEC:0001209191-15-021924:0
Canonical exit: 31 May 2015 (T+90)
25 of 32 declarations
About CONTRAFECT Corp
CONTRAFECT Corp is a biopharmaceutical company focused on developing treatments for bacterial infections. It is listed on NASDAQ under the ticker CNTF.
